Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$81.24 - $97.37 $1.81 Million - $2.17 Million
22,281 New
22,281 $1.84 Million
Q4 2023

Feb 09, 2024

BUY
$80.59 - $92.61 $836,927 - $961,754
10,385 New
10,385 $888,000
Q2 2023

Aug 14, 2023

BUY
$80.84 - $89.45 $659,654 - $729,912
8,160 New
8,160 $695,000
Q4 2022

Feb 13, 2023

BUY
$73.85 - $86.14 $1.53 Million - $1.79 Million
20,770 Added 426.49%
25,640 $2.02 Million
Q3 2022

Nov 14, 2022

SELL
$63.3 - $78.66 $384,864 - $478,252
-6,080 Reduced 55.53%
4,870 $361,000
Q2 2022

Aug 12, 2022

BUY
$49.27 - $66.08 $539,506 - $723,576
10,950 New
10,950 $714,000
Q1 2022

May 16, 2022

SELL
$43.77 - $63.22 $488,910 - $706,167
-11,170 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$49.55 - $74.59 $553,473 - $833,170
11,170 New
11,170 $592,000
Q2 2021

Aug 13, 2021

SELL
$51.81 - $118.56 $599,441 - $1.37 Million
-11,570 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$111.01 - $139.48 $1.28 Million - $1.61 Million
11,570 New
11,570 $1.28 Million
Q2 2020

Aug 14, 2020

SELL
$84.96 - $118.91 $610,012 - $853,773
-7,180 Closed
0 $0
Q1 2020

May 13, 2020

SELL
$74.34 - $121.82 $939,434 - $1.54 Million
-12,637 Reduced 63.77%
7,180 $716,000
Q4 2019

Feb 14, 2020

BUY
$114.37 - $129.46 $1.48 Million - $1.68 Million
12,970 Added 189.43%
19,817 $2.28 Million
Q3 2019

Nov 14, 2019

BUY
$117.16 - $138.52 $802,194 - $948,446
6,847 New
6,847 $864,000
Q3 2018

Nov 14, 2018

SELL
$89.96 - $114.58 $1.27 Million - $1.62 Million
-14,145 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$71.53 - $95.75 $606,788 - $812,247
8,483 Added 149.82%
14,145 $1.27 Million
Q1 2018

May 14, 2018

SELL
$60.72 - $74.41 $22,891 - $28,052
-377 Reduced 6.24%
5,662 $415,000
Q4 2017

Feb 09, 2018

BUY
$44.96 - $58.99 $271,513 - $356,240
6,039
6,039 $350,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.39B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.